Literature DB >> 24918986

Fmoc-based synthesis of disulfide-rich cyclic peptides.

Olivier Cheneval1, Christina I Schroeder, Thomas Durek, Phillip Walsh, Yen-Hua Huang, Spiros Liras, David A Price, David J Craik.   

Abstract

Disulfide-rich cyclic peptides have exciting potential as leads or frameworks in drug discovery; however, their use is faced with some synthetic challenges, mainly associated with construction of the circular backbone and formation of the correct disulfides. Here we describe a simple and efficient Fmoc solid-phase peptide synthesis (SPPS)-based method for synthesizing disulfide-rich cyclic peptides. This approach involves SPPS on 2-chlorotrityl resin, cyclization of the partially protected peptide in solution, cleavage of the side-chain protecting groups, and oxidization of cysteines to yield the desired product. We illustrate this method with the synthesis of peptides from three different classes of cyclic cystine knot motif-containing cyclotides: Möbius (M), trypsin inhibitor (T), and bracelet (B). We show that the method is broadly applicable to peptide engineering, illustrated by the synthesis of two mutants and three grafted analogues of kalata B1. The method reduces the use of highly caustic and toxic reagents and is better suited for high-throughput synthesis than previously reported methods for producing disulfide-rich cyclic peptides, thus offering great potential to facilitate pharmaceutical optimization of these scaffolds.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24918986     DOI: 10.1021/jo500699m

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  28 in total

1.  Backbone cyclization of analgesic conotoxin GeXIVA facilitates direct folding of the ribbon isomer.

Authors:  Xiaosa Wu; Yen-Hua Huang; Quentin Kaas; Peta J Harvey; Conan K Wang; Han-Shen Tae; David J Adams; David J Craik
Journal:  J Biol Chem       Date:  2017-08-28       Impact factor: 5.157

Review 2.  The synthesis, properties and potential applications of cyclic polymers.

Authors:  Farihah M Haque; Scott M Grayson
Journal:  Nat Chem       Date:  2020-04-06       Impact factor: 24.427

3.  Cellular Uptake and Cytosolic Delivery of a Cyclic Cystine Knot Scaffold.

Authors:  Huawu Yin; Yen-Hua Huang; Kirsten Deprey; Nicholas D Condon; Joshua A Kritzer; David J Craik; Conan K Wang
Journal:  ACS Chem Biol       Date:  2020-05-06       Impact factor: 5.100

4.  Chemical and biological production of cyclotides.

Authors:  Yilong Li; Tao Bi; Julio A Camarero
Journal:  Adv Bot Res       Date:  2015       Impact factor: 2.175

5.  Efficient enzymatic cyclization of an inhibitory cystine knot-containing peptide.

Authors:  Soohyun Kwon; Frank Bosmans; Quentin Kaas; Olivier Cheneval; Anne C Conibear; K Johan Rosengren; Conan K Wang; Christina I Schroeder; David J Craik
Journal:  Biotechnol Bioeng       Date:  2016-08-09       Impact factor: 4.530

6.  Constrained Cyclic Peptides as Immunomodulatory Inhibitors of the CD2:CD58 Protein-Protein Interaction.

Authors:  Rushikesh Sable; Thomas Durek; Veena Taneja; David J Craik; Sandeep Pallerla; Ted Gauthier; Seetharama Jois
Journal:  ACS Chem Biol       Date:  2016-07-01       Impact factor: 5.100

7.  Development of Novel Melanocortin Receptor Agonists Based on the Cyclic Peptide Framework of Sunflower Trypsin Inhibitor-1.

Authors:  Thomas Durek; Philipp M Cromm; Andrew M White; Christina I Schroeder; Quentin Kaas; Joachim Weidmann; Abdullah Ahmad Fuaad; Olivier Cheneval; Peta J Harvey; Norelle L Daly; Yang Zhou; Anita Dellsén; Torben Österlund; Niklas Larsson; Laurent Knerr; Udo Bauer; Horst Kessler; Minying Cai; Victor J Hruby; Alleyn T Plowright; David J Craik
Journal:  J Med Chem       Date:  2018-04-11       Impact factor: 7.446

8.  Discovery and mechanistic studies of cytotoxic cyclotides from the medicinal herb Hybanthus enneaspermus.

Authors:  Qingdan Du; Lai Y Chan; Edward K Gilding; Sónia Troeira Henriques; Nicholas D Condon; Anjaneya S Ravipati; Quentin Kaas; Yen-Hua Huang; David J Craik
Journal:  J Biol Chem       Date:  2020-05-15       Impact factor: 5.157

9.  A grafted peptidomimetic for EGFR heterodimerization inhibition: Implications in NSCLC models.

Authors:  Sitanshu S Singh; George Mattheolabakis; Xin Gu; Sita Withers; Achyut Dahal; Seetharama Jois
Journal:  Eur J Med Chem       Date:  2021-02-23       Impact factor: 6.514

10.  Oral activity of a nature-derived cyclic peptide for the treatment of multiple sclerosis.

Authors:  Kathrin Thell; Roland Hellinger; Emine Sahin; Paul Michenthaler; Markus Gold-Binder; Thomas Haider; Mario Kuttke; Zita Liutkevičiūtė; Ulf Göransson; Carsten Gründemann; Gernot Schabbauer; Christian W Gruber
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.